Ipca Laboratories is currently trading at Rs. 529.50, up by 6.45 points or 1.23% from its previous closing of Rs. 523.05 on the BSE.
The scrip opened at Rs. 529.00 and has touched a high and low of Rs. 532.45 and Rs. 525.10 respectively. So far 52008 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 888.00 on 19-Aug-2015 and a 52 week low of Rs. 402.00 on 06-Jun-2016.
Last one week high and low of the scrip stood at Rs. 537.40 and Rs. 493.75 respectively. The current market cap of the company is Rs. 6682.24 crore.
The promoters holding in the company stood at 45.90%, while institutions and non-institutions held 37.89% and 16.21% respectively.
Ipca Laboratories has reported over two fold jump in its net profit at Rs 47.57 crore for the quarter ended June 30, 2016 as compared to Rs 20.92 crore for the same quarter in the previous year. The company's total income increased by 11.19% to Rs 847.03 crore for the quarter under review from Rs 761.79 crore for the corresponding quarter of the previous year
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company's income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.